ELEVATUM Study:Roche’ Vabysmo Enhances Vision In Underrepresented Diabetic Macular Edema Populations
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo (faricimab) for the treatment of diabetic macular edema (DME) in people from racial and ethnic groups that are often underrepresented i
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1116617012-6a8112931e6f4375b6e1481b39eeeae8.jpg "How to Become a Real Estate Agent: A Step-by-Step Guide")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1255077848-13fe034d27ba4d1398930d76d7be6693.jpg "6 Best Paying Jobs in Finance")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1246195248-4209faa3f1854e648d38836ebd402e96.jpg "Forex Market Sentiment Indicators and How To Use Them")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1144526482-502cd0f081c9408bb9df5e768a5f6efe.jpg "The Stunning Earnings of the Biggest Movie Franchises—See How They Compare")